The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis

The Action of Inositols and Alpha-lactalbumin on Glucose Metabolism, Arterial Stiffness and Vascular Damage in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis

The study aims to evaluate the effects of an oral supplementation based on inositols and alpha-lactalbumin on principals metabolic parameters in patients with metabolic syndrome at risk of cardiac fibrosis

At least 3 of the following inclusion criteria:

• triglycerides levels ≥ 150 mg/dL
• HDL ≤ 40 mg/dL
• Fasting glycemia > 100 mg/dL <126 mg/dl
• Systolic Pressure ≥ 130 mmHg or Diastolic pressure ≥ 85 mmHg
• Hip circumference > 102 cm in men or 88 cm in women